117 related articles for article (PubMed ID: 3361571)
1. [1,2,4]Triazolo[4,3-a]quinoxalin-4-amines: a new class of A1 receptor selective adenosine antagonists.
Trivedi BK; Bruns RF
J Med Chem; 1988 May; 31(5):1011-4. PubMed ID: 3361571
[TBL] [Abstract][Full Text] [Related]
2. 4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Sarges R; Howard HR; Browne RG; Lebel LA; Seymour PA; Koe BK
J Med Chem; 1990 Aug; 33(8):2240-54. PubMed ID: 2374150
[TBL] [Abstract][Full Text] [Related]
3. 1-substituted 4-[chloropyrazolyl][1,2,4]triazolo[4,3-a]quinoxalines: synthesis and structure-activity relationships of a new class of benzodiazepine and adenosine receptor ligands.
Matuszczak B; Pekala E; Müller CE
Arch Pharm (Weinheim); 1998 May; 331(5):163-9. PubMed ID: 9691247
[TBL] [Abstract][Full Text] [Related]
4. 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists.
Müller CE; Hide I; Daly JW; Rothenhäusler K; Eger K
J Med Chem; 1990 Oct; 33(10):2822-8. PubMed ID: 2213835
[TBL] [Abstract][Full Text] [Related]
5. 4-Amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo [4,3-alpha]-quinoxalin-1-one: a new A2A adenosine receptor antagonist with high selectivity versus A1 receptors.
Colotta V; Catarzi D; Varano F; Cecchi L; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Arch Pharm (Weinheim); 1999 Feb; 332(2):39-41. PubMed ID: 10233008
[No Abstract] [Full Text] [Related]
6. Synthesis, ligand-receptor modeling studies and pharmacological evaluation of novel 4-modified-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent and selective human A3 adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Traini C; Pugliese AM; Pedata F; Morizzo E; Moro S
Bioorg Med Chem; 2008 Jun; 16(11):6086-102. PubMed ID: 18468446
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of 4-cycloalkylamino-1, 2, 4-triazolo[4, 3-a]quinoxalin-1- one derivatives as A1 and A3 adenosine receptor antagonists.
Colotta V; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A; Colotta V
Arch Pharm (Weinheim); 2004 Jan; 337(1):35-41. PubMed ID: 14760626
[TBL] [Abstract][Full Text] [Related]
8. 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.
Catarzi D; Colotta V; Varano F; Filacchioni G; Martini C; Trincavelli L; Lucacchini A
Farmaco; 2004 Feb; 59(2):71-81. PubMed ID: 14871498
[TBL] [Abstract][Full Text] [Related]
9. Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
Baraldi PG; Cacciari B; Spalluto G; Pineda de las Infantas y Villatoro MJ; Zocchi C; Dionisotti S; Ongini E
J Med Chem; 1996 Mar; 39(5):1164-71. PubMed ID: 8676354
[TBL] [Abstract][Full Text] [Related]
10. 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.
Colotta V; Catarzi D; Varano F; Calabri FR; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Deflorian F; Moro S
J Med Chem; 2004 Jul; 47(14):3580-90. PubMed ID: 15214785
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.
Francis JE; Cash WD; Psychoyos S; Ghai G; Wenk P; Friedmann RC; Atkins C; Warren V; Furness P; Hyun JL
J Med Chem; 1988 May; 31(5):1014-20. PubMed ID: 3361572
[TBL] [Abstract][Full Text] [Related]
12. Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors.
Jacobson KA; Kiriasis L; Barone S; Bradbury BJ; Kammula U; Campagne JM; Secunda S; Daly JW; Neumeyer JL; Pfleiderer W
J Med Chem; 1989 Aug; 32(8):1873-9. PubMed ID: 2754711
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4- oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists.
Catarzi D; Colotta V; Varano F; Calabri FR; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2004 Jan; 47(1):262-72. PubMed ID: 14695840
[TBL] [Abstract][Full Text] [Related]
14. New 1,2,3-triazolo[1,5-a]quinoxalines: synthesis and binding to benzodiazepine and adenosine receptors. II.
Biagi G; Giorgi I; Livi O; Scartoni V; Betti L; Giannaccini G; Trincavelli ML
Eur J Med Chem; 2002 Jul; 37(7):565-71. PubMed ID: 12126775
[TBL] [Abstract][Full Text] [Related]
15. 7-Deaza-9-phenyladenines. A new class of adenosine receptor antagonists.
Daly JW; Padgett WL; Eger K
Biochem Pharmacol; 1988 Oct; 37(19):3749-53. PubMed ID: 3178888
[TBL] [Abstract][Full Text] [Related]
16. 8-Aryl-and 8-cycloalkyl-1,3-dipropylxanthines: further potent and selective antagonists for A1-adenosine receptors.
Shamim MT; Ukena D; Padgett WL; Hong O; Daly JW
J Med Chem; 1988 Mar; 31(3):613-7. PubMed ID: 3346878
[TBL] [Abstract][Full Text] [Related]
17. 3H-[1,2,4]-Triazolo[5,1-i]purin-5-amine derivatives as adenosine A2A antagonists.
Silverman LS; Caldwell JP; Greenlee WJ; Kiselgof E; Matasi JJ; Tulshian DB; Arik L; Foster C; Bertorelli R; Monopoli A; Ongini E
Bioorg Med Chem Lett; 2007 Mar; 17(6):1659-62. PubMed ID: 17234414
[TBL] [Abstract][Full Text] [Related]
18. Potent adenosine receptor antagonists that are selective for the A1 receptor subtype.
Martinson EA; Johnson RA; Wells JN
Mol Pharmacol; 1987 Mar; 31(3):247-52. PubMed ID: 3561384
[TBL] [Abstract][Full Text] [Related]
19. N6-phenyladenosines: pronounced effect of phenyl substituents on affinity for A2 adenosine receptors.
Kwatra MM; Leung E; Hosey MM; Green RD
J Med Chem; 1987 May; 30(5):954-6. PubMed ID: 3572985
[TBL] [Abstract][Full Text] [Related]
20. 7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1, 5-a]quinoxaline-2- carboxylates as novel highly selective AMPA receptor antagonists.
Catarzi D; Colotta V; Varano F; Cecchi L; Filacchioni G; Galli A; Costagli C; Carlà V
J Med Chem; 2000 Oct; 43(21):3824-6. PubMed ID: 11052786
[No Abstract] [Full Text] [Related]
[Next] [New Search]
